Welcome Customer !

Membership

Help

Guangzhou Taiwei Biotechnology Co., Ltd
Custom manufacturer

Main Products:

instrumentb2b>Article

Guangzhou Taiwei Biotechnology Co., Ltd

  • E-mail

    info@techway-gz.com

  • Phone

  • Address

    7th Floor, Building A2, No. 17 Xicheng Middle Street, Huangpu District, Guangzhou City

Contact Now
The core competitiveness of Thermo Fisher columns lies in the deep exploration and innovation of materials science
Date: 2025-08-14Read: 0

In the field of modern analytical chemistry, efficient and precise separation technology is the core cornerstone of scientific research and industrial production. Thermo Fisher columns, with their performance, innovative material design, and wide range of application scenarios, have become a key tool for promoting the development of fields such as life sciences, pharmaceutical research and development, and environmental monitoring. From the analysis of microscopic molecular structures to the quality control of macroscopic industrial production, this technological light has always illuminated the forefront of separation science. ​

The core competitiveness of Thermo Fisher columns lies in the deep exploration and innovation of materials science. The Hypercarb series adopts a 100% porous graphite carbon stationary phase, which is composed of hexagonal carbon atom stacks, endowing the chromatographic column with extraordinary chemical stability in the range of 0-14PH. Experimental data shows that this series can clearly separate carbohydrate derivatives with only one hydroxyl group difference in structure, breaking through the limitations of traditional silica gel matrix chromatography columns in separating polar compounds. In the field of biomacromolecule separation, the 550 SEC chromatography column uses 3 μ m monodisperse silica gel particle technology, which reduces the diffusion effect of protein separation by 40% through precise control of pore size distribution. After a certain biopharmaceutical company used this product, the purification cycle of antibody drugs was shortened from 6 hours to 90 minutes, and the single batch yield increased by three times. More noteworthy is its inert technology treatment, which shields ion exchange sites and improves the compatibility between chromatography columns and mass spectrometry detectors by 85%, making it a key tool for biopharmaceutical development. ​

Faced with complex and diverse analysis requirements, Thermo Fisher has built a product matrix covering all scenarios. The Acclaim 300 C18 chromatographic column uses 3 μ m pure silica gel particles, achieving a separation efficiency three times that of a traditional 5 μ m chromatographic column within a column length of 150mm. When a CRO company used this product for peptide mapping analysis, it successfully resolved a complex peptide segment containing 20 amino acids with a separation degree of over 1.8, meeting the strict requirements of FDA for the confirmation of biopharmaceutical structures. In the field of ion exchange, POROS ™ The HQ50 RoboColumn has undergone a design revolution with an 8-row miniaturized design. This 50 μ m strong anion exchange packed chromatography column can operate stably at a pressure of 116 psi, with a single purification yield of 600 μ L. A gene therapy company has utilized this technology to increase the purification yield of AAV viral vectors from 65% to 89%, providing critical support for CAR-T therapy development. For ultra-high throughput analysis requirements, the Aurora Ultimate 25cm chromatographic column uses 1.7 μ m special packing and nanoZero technology to achieve zero dead volume connection between the nozzle and the column front. In the 60 minute gradient separation, this product can stably detect more than 2000 proteins in the plasma, with a repeatability CV value of less than 5%, making it a tool for clinical proteomics research. ​

In addition to its hardware performance, Thermo Fisher Scientific has also deeply integrated artificial intelligence technology into the research and development of chromatography columns. The UMISil C18 chromatographic column was optimized for the end capping process using machine learning algorithms, resulting in a 90% reduction in silanol activity. In the analysis of traditional Chinese medicine components such as quercetin, the peak shape symmetry factor reached 1.2, eliminating the phenomenon of peak tailing. After a certain traditional Chinese medicine enterprise used this product, the quality control testing flux increased by three times, and the method reproducibility met the ISO/IEC 17025 standard. In terms of production process, the 550 SEC chromatography column uses a laser diffraction particle size analyzer to monitor the packing process in real time, and the fluctuation of column efficiency for each batch of products is controlled within ± 2%. This precision manufacturing process has increased the success rate of analysis method transfer for a certain mRNA vaccine company from 75% to 98%, significantly shortening the new drug launch cycle. ​

From basic laboratory research to industrial scale production, from quality control in drug development to trace detection of environmental pollutants, Thermo Fisher columns have become a reliable partner for scientists exploring the unknown world and engineers ensuring production safety due to their separation performance, stable product quality, and continuous innovation vitality. It is not only the core component of analytical instruments, but also a bridge connecting scientific research and industrial transformation. As analytical science advances towards higher sensitivity, faster speed, and stronger selectivity, Thermo Fisher columns will continue to drive industry development with technological innovation, writing more possibilities in fields such as life and health, environmental protection, and new material research and development.